Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Why Big Pharma Wants To Collect 2 Million Genomes

    Sep 28, 2016, 12:26 PM by Michael Croft
    Nature News & Comment | For the head of AstraZeneca's genomics initiative, the challenge is not just getting the sequences, but in putting them to use - wisely.
    Full story
  • Microsoft Goes All in for FPGAs to Build Out AI Cloud

    Sep 28, 2016, 11:26 AM by Michael Croft
    TOP500 Supercomputer Sites | Microsoft has revealed that Altera FPGAs have been installed across every Azure cloud server, creating what the company is calling "the world's first AI supercomputer."
    Full story
  • Addressing Common Roadblocks In Drug Development: Keynotes At 2016 Discovery On Target

    Sep 28, 2016, 11:25 AM by Michael Croft

    Bio-IT World | There is tremendous unlocked potential for new therapeutic drugs. Some of the key aspects of drug development were addressed with novel solutions in compelling plenary keynote talks at the 2016 Discovery on Target Conference in Boston last week.

    Full story
  • ZENITH TECHNOLOGIES APPOINTS MES LEAD

    Sep 28, 2016, 06:40 AM by Michael Croft
    BLUEBELL, PA - Sep 28, 2016 - A global life science technology firm has appointed James O’Brien to lead its manufacturing execution system (MES) business to its next phase of growth
    Full story
  • Unmet Medical Needs of Population in Emerging Economies will Support Acute Care Management

    Sep 28, 2016, 04:42 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Sep 28, 2016 - Acute care is a branch of secondary health care in which short term treatment is provided to patients for their various medical conditions such as severe injury and recovery from surgery
    Full story
  • Creative Biolabs Released Anti-idiotypic Antibody Production Service for Antibody Drug Development

    Sep 27, 2016, 22:21 PM by Michael Croft
    SHIRLEY, NY, USA - Sep 28, 2016 - With years of experience in antibody research and development, Creative Biolabs released anti-idiotypic antibody production service to further support researchers in the field of antibody related studies
    Full story
  • PRP a Biologic Treatment Helping Innovate Pain Relief Techniques!

    Sep 27, 2016, 15:28 PM by Michael Croft
    FULLERTON,, CA, UNITED STATES - Sep 28, 2016 - PRP is a Biologic Treatment. PRP is a Pain Management Alternative method of nonsurgical management of soft-tissue and musculoskeletal conditions
    Full story
  • Color Genomics Raises $45 Million To Expand Genetic Testing

    Sep 27, 2016, 11:31 AM by Michael Croft
    Bloomberg | Color Genomics Inc., the three-year-old startup aiming to democratize genetic testing, sealed $45 million in funding as it seeks to make its tests for cancer more affordable and accessible, the company announced Tuesday.
    Full story
  • Kite Unveils Anticipated CAR-T Cancer Data Positive But Not Complete

    Sep 27, 2016, 10:52 AM by Michael Croft
    Xconomy | Kite Pharma has dipped into a highly anticipated clinical trial of its cancer treatment, KTE-C19, to release a partial set of data. Although not complete, the data bolster the view that Kite could be the first among its peers to win the FDA's green light.
    Full story
  • GenomeNext Launches Innovative Olympus Platform to Integrate Genetic Testing, Delivering Fully Automated Solution to Drive Personalized Medicine Programs

    Sep 27, 2016, 07:28 AM by Michael Croft
    COLUMBUS, OH - Sep 27, 2016 - Columbus, OH - GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today the launch of Olympus; a powerful, innovative platform designed to simplify and automate 'Omics-based analysis and interpretation into a single, consolidated solution
    Full story
  • The Sequencing App and the Quest for Fun

    Sep 26, 2016, 17:20 PM by Michael Croft

    Bio-IT World | The latest way to get into your genome is a $50 app-based venture that promises to give you a peek into your ancestry and tell you what kinds of bacteria you’re harboring in your mouth. Seeq launched earlier this month offering ultra-low coverage sequencing of the genome, oral microbiome sequencing, and ancestry reports. The goal is an extremely inexpensive infrastructure for people to get a little bit of genomic data and participate in research in a way that’s easy and fun.

    Full story
  • Sanford Health Selects GenomeNext to Provide Enterprise Genomic Analysis Platform for Personalized Medicine Programs

    Sep 26, 2016, 17:15 PM by Michael Croft
    COLUMBUS, OH - Sep 20, 2016 - GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that Sanford Health, a Dakotas-based non-profit health system, and one of the largest integrated health systems in the nation, has selected GenomeNext’s Olympus Platform to deliver comprehensive genomic analysis and data management capabilities to expand its personalized medicine program across multiple U
    Full story
  • How to Prevent Osteoporosis - Information, Prevention & Tips

    Sep 26, 2016, 14:28 PM by Michael Croft
    FULLERTON, CA, UNITED STATES - Sep 26, 2016 - Preventing OsteoporosisWhile it is one of the most common bone diseases, it is also one of the most preventable as well
    Full story
  • Cutting Edge Plant Technology Inspires the Danforth Center's Fall Symposium

    Sep 26, 2016, 12:55 PM by Michael Croft
    ST. LOUIS, UNITED STATES - Sep 26, 2016 - The Donald Danforth Plant Science Center’s 18th annual Fall Symposium kicks off this week, September 28-30
    Full story
  • Top Scientists Cautious About Curing Cancer With Immunotherapy

    Sep 26, 2016, 10:17 AM by Michael Croft
    STAT | There's been a lot of excitement about immunotherapy as a tool to treat cancer. But top experts on Sunday struck an unexpected note of caution.
    Full story
  • Healthcare EDI Market to Exhibit High Growth Rate due to Rising Research and Development Activities

    Sep 26, 2016, 07:37 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Sep 26, 2016 - Electronic Data Interchange, abbreviated as EDI, is an innovative electronic communication technology, that offers exchange data standards, for exchange of data by any kind of electronic technology
    Full story
  • Introduction of Mobile Healthcare has Greatly Influenced Medical Science

    Sep 26, 2016, 03:23 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Sep 26, 2016 - The introduction of a wide range of portable handheld devices has substantially influenced various fields; medical science being one of them
    Full story
  • 6 Key Benefits of Exercise - Fitness Tips

    Sep 25, 2016, 15:21 PM by Michael Croft
    GURNEE, IL, UNITED STATES - Sep 26, 2016 - Improving Your Overall Health -  Regular exercise is one of the best things that you can do for your body
    Full story
  • Stem Cells for Arthritis - Innovation in Technology and Medicine

    Sep 24, 2016, 16:32 PM by Michael Croft
    AURORA, IL, UNITED STATES - Sep 24, 2016 - What is Arthritis?More commonly found in people over 60, Arthritis is a condition that affects the joints of the body
    Full story
  • Stem Cell Therapy - Specialized Cells with the Ability to Self-Replicate Could Reform Healthcare!

    Sep 24, 2016, 06:53 AM by Michael Croft
    WESTMINSTER, CA, UNITED STATES - Sep 24, 2016 - Stem Cell TherapyStem cells refer to a group of body cells which are able to differentiate to form specialized cells
    Full story
  • «
  • 331 (current)
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338
  • 339
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy